
Metrics In Balance (MLMIB) | Financial Analysis & Statements
Metrics In Balance S.A. | Small-cap | Healthcare
Metrics In Balance S.A. | Small-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
No financial overview data available.
Metrics In Balance Income Statement From 2018 to 2022
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 300 | 55.0K | 41.3K | 32.7K | 1.3K |
Cost of Goods Sold | 52.3K | 92.0K | 26.9K | 106.3K | 186.3K |
Gross Profit | -52.0K | -37.0K | 14.4K | -73.6K | -185.0K |
Gross Margin % | -17,317.0% | -67.3% | 34.9% | -224.8% | -13,711.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 122 | 120 | 119 | 2.0K | 160 |
Total Operating Expenses | 122 | 120 | 119 | 2.0K | 160 |
Operating Income | -41.8K | -57.1K | -1.5K | -105.0K | -297.8K |
Operating Margin % | -13,929.0% | -103.8% | -3.6% | -320.9% | -22,072.5% |
Non-Operating Items | |||||
Interest Income | 1.6K | 1.0K | 7.5K | 1.9K | 635 |
Interest Expense | 7.1K | 3.0K | 3.5K | 2.9K | 1.5K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -53.5K | 2.6K | 871 | -107.5K | -300.4K |
Income Tax | - | - | 0 | 453 | 255 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -53.5K | 2.6K | 871 | -108.0K | -300.7K |
Net Margin % | -17,819.7% | 4.7% | 2.1% | -330.0% | -22,288.1% |
Key Metrics | |||||
EBITDA | -35.2K | 25.7K | 37.1K | -75.2K | -280.7K |
EPS (Basic) | - | €0.00 | €0.00 | €-0.02 | €-0.15 |
EPS (Diluted) | - | €0.00 | €0.00 | €-0.02 | €-0.15 |
Basic Shares Outstanding | - | 4390543 | 4390543 | 4390543 | 2050000 |
Diluted Shares Outstanding | - | 4390543 | 4390543 | 4390543 | 2050000 |
Income Statement Trend
Metrics In Balance Balance Sheet From 2018 to 2022
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 481 | 1.8K | 81 | 7.9K | 3.9K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 267.5K | 137.1K | 87.7K | 116.9K | 12.8K |
Inventory | 15.0K | 18.2K | 18.6K | - | - |
Other Current Assets | - | 1 | - | - | - |
Total Current Assets | 289.6K | 162.2K | 207.0K | 127.2K | 20.9K |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 2.2K | 8.6K | 15.8K | 23.2K | 25.1K |
Total Non-Current Assets | 12.3M | 12.3M | 12.1M | 12.1M | 61.9K |
Total Assets | 12.6M | 12.4M | 12.3M | 12.2M | 82.8K |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 127.3K | 121.5K | 59.5K | 92.0K | 54.2K |
Short-term Debt | 37.9K | 100.0K | 100.0K | 100.0K | 100.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 449.8K | 372.2K | 298.9K | 177.9K | 246.8K |
Total Current Liabilities | 638.5K | 631.4K | 476.8K | 429.7K | 453.7K |
Non-Current Liabilities | |||||
Long-term Debt | 197.2K | - | - | - | - |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | -1 | - | - | - | - |
Total Non-Current Liabilities | 197.2K | 0 | 0 | 0 | 1 |
Total Liabilities | 835.7K | 631.4K | 476.8K | 429.7K | 453.7K |
Equity | |||||
Common Stock | 12.4M | 12.4M | 12.4M | 12.4M | 161.5K |
Retained Earnings | -690.4K | -636.9K | -639.5K | -640.4K | -532.4K |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 11.7M | 11.8M | 11.8M | 11.8M | -370.9K |
Key Metrics | |||||
Total Debt | 235.1K | 100.0K | 100.0K | 100.0K | 100.0K |
Working Capital | -348.9K | -469.3K | -269.8K | -302.5K | -432.8K |
Balance Sheet Composition
Metrics In Balance Cash Flow Statement
No cash flow data available.
Metrics In Balance Key Financial Ratios
Valuation Ratios
Price to Book
0.01
Price to Sales
2,634.32
Profitability Ratios
Profit Margin
-17,317.00%
Operating Margin
-15,429.00%
Return on Equity
-0.45%
Return on Assets
-0.23%
Financial Health
Current Ratio
0.45
Beta
0.16
Per Share Data
EPS (TTM)
€-0.01
Book Value per Share
€2.68
Revenue per Share
€0.00
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
mlmib | 790.3K | - | 0.01 | -0.45% | -17,317.00% | - |
Bastide le Confort | 207.6M | 24.48 | 2.77 | 10.46% | 0.32% | 541.81 |
Laboratoires | 12.1M | 28.20 | 0.73 | -31.26% | -16.78% | 48.76 |
EssilorLuxottica | 127.0B | 52.88 | 3.31 | 6.44% | 8.74% | 36.58 |
Sartorius Stedim | 17.6B | 76.84 | 4.40 | 5.69% | 7.78% | 73.51 |
bioMérieux S.A | 15.0B | 35.00 | 3.57 | 10.68% | 10.86% | 11.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.